Skip to main content
OpenTrials

Clinical trial condition

Virus Diseases

Explore clinical trials studying Virus Diseases. Study availability and eligibility vary by location and protocol.

18,936 public trials 1,286 recruiting studies
Refine in advanced search Browse all conditions

Virus Diseases trial results

Active, Not Recruiting

A Study to Evaluate VXA-CoV2-3.3 COVID-19 Vaccine Against Currently Approved/Authorized mRNA COVID-19 Injectable Booster Vaccine in Adults Previously Immunized Against COVID-19 Infection

NCT06672055

Conditions
COVID-19, Coronaviridae Infections, Coronavirus Infections, +10 more
Locations
  • Pinnacle Research Group Anniston, Alabama, United States
  • Core Clinical Trials - Central Alabama Research LLC Birmingham, Alabama, United States
  • Coastal Clinical Research Mobile, Alabama, United States
  • Avacare - Lenzmeier Family Medicine Glendale, Arizona, United States
View all 145 locations
View Trial Details
Active, Not Recruiting

Individualized Treatment Treating Patients With Stage II-IVB Nasopharyngeal Cancer Based on EBV DNA

NCT02135042

Conditions
Carcinoma, DNA Virus Infections, Epstein-Barr Virus Infection, +22 more
Locations
  • University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
  • The Kirklin Clinic at Acton Road Birmingham, Alabama, United States
  • Banner University Medical Center - Tucson Tucson, Arizona, United States
  • Sutter Cancer Centers Radiation Oncology Services-Auburn Auburn, California, United States
View all 215 locations
View Trial Details
Active, Not Recruiting

The LATITUDE Study: Long-Acting Therapy to Improve Treatment SUccess in Daily LifE

NCT03635788

Conditions
Blood-Borne Infections, Communicable Diseases, Genital Diseases, +11 more
Locations
  • Alabama CRS Birmingham, Alabama, United States
  • University of Southern California CRS Los Angeles, California, United States
  • UCLA CARE Center CRS Los Angeles, California, United States
  • UCSD Antiviral Research Center CRS San Diego, California, United States
View all 33 locations
View Trial Details
Active, Not Recruiting

Long-term Follow-up Study to Evaluate Durability of Treatment Response in Previous Bepirovirsen Study Participants (B-Sure)

NCT04954859

Conditions
Blood-Borne Infections, Communicable Diseases, DNA Virus Infections, +8 more
Locations
  • GSK Investigational Site Sacramento, California, United States
  • GSK Investigational Site San Jose, California, United States
  • GSK Investigational Site Colorado Springs, Colorado, United States
  • GSK Investigational Site Boston, Massachusetts, United States
View all 163 locations
View Trial Details
Active, Not Recruiting

A Safety and Immunogenicity Trial of Boost-2867 Vaccine, Via Intranasal and Intramuscular Routes

NCT07221162

Conditions
COVID-19, Coronaviridae Infections, Coronavirus Infections, +9 more
Locations
  • University of California San Francisco - Zuckerberg San Francisco General Hospital - Division of Human Immunodeficiency Virus, Infectious Disease, and Global Medicine San Francisco, California, United States
  • Center for Immunization Research, Johns Hopkins Bloomberg School Public Health Baltimore, Maryland, United States
  • Saint Louis University Center for Vaccine Development St Louis, Missouri, United States
  • University of Rochester Medical Center - Vaccine Research Unit Rochester, New York, United States
View Trial Details

Related conditions